1. NBTS Immunoglobulin Working Party. Recommendations for the use of anti-D immunoglobulin;Prescribers Journal,1991
2. Committee for Proprietary Medicinal Products. Note for guidance: core summary ofproduct characteristics for human anti-D immunoglobulin, im;Brussels: Commission of European Communities,1992
3. Working Party on the Use of Anti-D Immunoglobulin for the Prevention of Isoimmunization of Rh-Negative Women During Pregnancy. Controlled trial of various anti-D dosages in suppression of Rh sensitization following pregnancy;BMJ,1974
4. the McMaster conference on prevention of Rh immunisation;Proceedings of,1979
5. Late assessment of thrombolytic efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction;Group, L.A.T.E.Study;Lancet,1993